Timothy Arthur James Haystead

Affiliations: 
1991-1999 Pharmacology University of Virginia, Charlottesville, VA 
 2000- Pharmacology & Cancer Biology Duke University, Durham, NC 
Area:
Biochemistry
Website:
https://medschool.duke.edu/about-us/our-faculty/timothy-arthur-james-haystead
Google:
"Timothy Arthur James Haystead"
Bio:

http://www.haysteadlab.com/Haystead_biosketch.pdf
http://app.dundee.ac.uk/pressoffice/thebridge/alumni/stars.htm

Mean distance: (not calculated yet)
 

Children

Sign in to add trainee
David Loiselle research assistant 2007- Duke
Tiffany Freed research assistant 2000-2001 Duke
Meridth Borman grad student UVA
Patrick Fadden grad student UVA
Anisa Scott grad student UVA
Karen Winkfield grad student Duke
Aaron Smith grad student 2012- Duke
Scott Scarneo grad student 2018- Duke
Maddy Sell grad student 2018- Duke
Arild Shirazi grad student 1992-1996 UVA
Jeff Partridge grad student 1994-1996 UVA
Geoffrey R. Alms grad student 2000 UVA
Jesse Kwiek grad student 1998-2003 University Virginia
Nicole C. Kwiek grad student 2005 Duke (Cell Biology Tree)
Anne A. Wooldridge grad student 2005 Duke (Cell Biology Tree)
Laura L. Hagerty grad student 2007 Duke (Cell Biology Tree)
Nisha Philip grad student 2007 Duke (Cell Biology Tree)
Rupa Ray grad student 2007 Duke (Cell Biology Tree)
Brittany Speer grad student 2006-2010 Duke
Jenica Chambers grad student 2003-2011 Duke
Jarad Barrott grad student 2010-2014 Duke
Matt Howe grad student 2010-2014 Duke
Yazan Alwarawrah grad student 2012-2016 Duke
Lauren B. Crowe grad student 2014-2017 Duke (FlyTree)
Juliane Totzke grad student 2015-2018 Duke
Paul Graves post-doc Duke
Doug Wetzel post-doc Duke
David A. Carlson post-doc 2010- Duke
Mani Campos post-doc 1993-1998 UVA
Cynthia Damer post-doc 1998-1998 UVA
Klaus Hardemann post-doc 2000-2001 Duke
Kathleen Verleysen post-doc 2000-2001 Duke
Justin McDonald post-doc 1998-2002 UVA & Duke
Bea Lontay post-doc 2008-2011 Duke
Khaldon Bodoor post-doc 2011-2014 Duke
Philip F. Hughes research scientist Duke
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Scarneo S, Hughes P, Freeze R, et al. (2022) Development and Efficacy of an Orally Bioavailable Selective TAK1 Inhibitor for the Treatment of Inflammatory Arthritis. Acs Chemical Biology
Wang Y, Scarneo SA, Kim SH, et al. (2021) Expression of ectopic heat shock protein 90 in male and female primary afferent nociceptors regulates inflammatory pain. Pain
Goswami R, Russell VS, Tu JJ, et al. (2021) Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells. Iscience. 103412
Osada T, Crosby EJ, Kaneko K, et al. (2021) HSP90-specific nIR probe identifies aggressive prostate cancers: translation from preclinical models to a human phase I study. Molecular Cancer Therapeutics
Woodford MR, Baker-Williams AJ, Sager RA, et al. (2021) The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effect. Nature Structural & Molecular Biology. 28: 662-670
Wang R, Alvarez DA, Crouch BT, et al. (2021) Understanding the sources of errors in Hsp90 molecular imaging for rapid-on-site breast cancer diagnosis. Biomedical Optics Express. 12: 2299-2311
Smith AD, Garcia-Santamarina S, Ralle M, et al. (2021) Transcription factor-driven alternative localization of Cryptococcus neoformans superoxide dismutase. The Journal of Biological Chemistry. 100391
Dong B, Jaeger AM, Hughes PF, et al. (2020) Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1. Science Translational Medicine. 12
Kaneko K, Osada T, Morse MA, et al. (2020) Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors. Communications Biology. 3: 226
Crouch BT, Gallagher J, Wang R, et al. (2019) Exploiting heat shock protein expression to develop a non-invasive diagnostic tool for breast cancer. Scientific Reports. 9: 3461
See more...